Ethic Inc’s Iovance Biotherapeutics IOVA Stock Holding History

Ethic Inc’s Portfolio IOVA Stock Details IOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-10,242	Closed	-$82.1K	–	1137
2024 Q2	$82.1K	Buy	+10,242	New	+$110K	﹤0.01%	1079

Other funds holding IOVA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

MFM

MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Ethic Inc's IOVA Position: Q3 2024 in Review

Ethic Inc sold out of Iovance Biotherapeutics (IOVA) in Q3 2024, closing a stake of 10,242 shares — an estimated $82.1K sold.

Ethic Inc first reported a position in IOVA in Q2 2024 and held it in 1 quarter. The position peaked at $82.1K in Q2 2024. 286 funds tracked by Wall St. Rank hold IOVA as of Q3 2024.

Ethic Inc reported no remaining Iovance Biotherapeutics position as of Q3 2024 after selling out during the quarter.
Ethic Inc sold 10,242 Iovance Biotherapeutics shares in Q3 2024, an estimated $82.1K.
Ethic Inc first reported a position in Iovance Biotherapeutics in Q2 2024 and held it in 1 quarter.
Ethic Inc's Iovance Biotherapeutics position peaked at $82.1K in Q2 2024.
286 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2024.

Based on Ethic Inc's 13F filing for Q3 2024, filed 13 Nov 2024.